Onoe, H.; Hirooka, K.; Baba, T.; Nagayama, M.; Hirota, A.; Suzuki, K.; Sagara, T.; Mochizuki, H.; Kiuchi, Y.
The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients. J. Clin. Med. 2024, 13, 4158.
https://doi.org/10.3390/jcm13144158
AMA Style
Onoe H, Hirooka K, Baba T, Nagayama M, Hirota A, Suzuki K, Sagara T, Mochizuki H, Kiuchi Y.
The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients. Journal of Clinical Medicine. 2024; 13(14):4158.
https://doi.org/10.3390/jcm13144158
Chicago/Turabian Style
Onoe, Hiromitsu, Kazuyuki Hirooka, Tetsuya Baba, Mikio Nagayama, Atsushi Hirota, Katsuyoshi Suzuki, Takeshi Sagara, Hideki Mochizuki, and Yoshiaki Kiuchi.
2024. "The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients" Journal of Clinical Medicine 13, no. 14: 4158.
https://doi.org/10.3390/jcm13144158
APA Style
Onoe, H., Hirooka, K., Baba, T., Nagayama, M., Hirota, A., Suzuki, K., Sagara, T., Mochizuki, H., & Kiuchi, Y.
(2024). The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients. Journal of Clinical Medicine, 13(14), 4158.
https://doi.org/10.3390/jcm13144158
